TickerFacts.

A business in context

ENTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. DEF 14A · Proxy statement

    Report date 2026-10-14 · 0001178913-26-004771

  2. 8-K · Current report

    Report date 2026-10-06 · 0001178913-26-004720 · Items 5.02,7.01,9.01

  3. 8-K · Current report

    Report date 2026-08-18 · 0001178913-26-004178 · Items 7.01,8.01,9.01

  4. 4 · Ownership change

    Report date 2026-08-07 · 0001178913-26-003957

  5. 4 · Ownership change

    Report date 2026-08-07 · 0001178913-26-003956

  6. 4 · Ownership change

    Report date 2026-08-07 · 0001178913-26-003955

  7. 4 · Ownership change

    Report date 2026-08-07 · 0001178913-26-003954

  8. 4 · Ownership change

    Report date 2026-08-07 · 0001178913-26-003953

  9. 4 · Ownership change

    Report date 2026-08-07 · 0001178913-26-003952

  10. 4 · Ownership change

    Report date 2026-08-07 · 0001178913-26-003951

  11. 4 · Ownership change

    Report date 2026-08-07 · 0001178913-26-003950

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001178913-26-003947

  13. 8-K · Current report

    Report date 2026-08-07 · 0001178913-26-003946 · Items 2.02,7.01,9.01

  14. 8-K · Current report

    Report date 2026-07-26 · 0001178913-26-003617 · Items 1.01,3.02,5.02,9.01

  15. 8-K · Current report

    Report date 2026-07-14 · 0001178913-26-003510 · Items 5.02,5.03,5.07,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-03 · 0001178913-26-003077

  17. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001178913-26-002458

  18. 8-K · Current report

    Report date 2026-05-08 · 0001178913-26-002455 · Items 2.02,7.01,9.01

  19. 8-K · Current report

    Report date 2026-04-01 · 0001178913-26-002001 · Items 1.01,3.02,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001178913-26-001797

  21. 8-K · Current report

    Report date 2026-03-27 · 0001178913-26-001792 · Items 2.02,7.01,9.01

  22. 8-K · Current report

    Report date 2026-03-04 · 0001178913-26-000714 · Items 7.01,9.01

  23. 8-K · Current report

    Report date 2026-02-04 · 0001178913-26-000355 · Items 5.02,7.01,9.01

  24. 8-K · Current report

    Report date 2026-01-29 · 0001178913-26-000300 · Items 1.01,5.02,7.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001178913-25-003852

  26. 8-K · Current report

    Report date 2025-11-14 · 0001178913-25-003851 · Items 2.02,7.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001178913-25-002702

  28. 8-K · Current report

    Report date 2025-08-08 · 0001178913-25-002701 · Items 2.02,7.01,9.01

  29. 8-K · Current report

    Report date 2025-07-28 · 0001178913-25-002484 · Items 7.01,8.01,9.01

  30. 8-K · Current report

    Report date 2025-07-16 · 0001178913-25-002406 · Items 5.07

  31. DEF 14A · Proxy statement

    Report date 2025-06-05 · 0001178913-25-002111

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001178913-25-001674

  33. 8-K · Current report

    Report date 2025-05-09 · 0001178913-25-001673 · Items 2.02,7.01,9.01

  34. 10-K · Annual report

    Report date 2024-12-31 · 0001178913-25-001112

  35. 8-K · Current report

    Report date 2025-03-28 · 0001178913-25-001110 · Items 2.02,7.01,9.01

  36. 8-K · Current report

    Report date 2025-03-16 · 0001178913-25-000857 · Items 1.01,3.02,7.01,9.01

  37. 8-K · Current report

    Report date 2025-01-10 · 0001178913-25-000080 · Items 9.01

  38. 8-K/A · Current report

    Report date 2024-07-31 · 0001178913-24-004020 · Items 5.07

  39. SC 13G/A · Ownership disclosure

    0001104659-24-120961

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001178913-24-003558

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 17 transaction rows17AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

17 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-07
2026-08-07
Rubin Steven DA · Grant / award
Acquired
Ordinary Shares, par value NIS 0.0000769 per share19117.00.0
2026-08-07
2026-08-07
Rubin Steven DA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
43405.00.0
2026-08-07
2026-08-07
Rubin Steven DA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
33368.00.0
2026-08-07
2026-08-07
Malca YonatanA · Grant / award
Acquired
Ordinary Shares, par value NIS 0.0000769 per share22815.00.0
2026-08-07
2026-08-07
Taitel HayaA · Grant / award
Acquired
Ordinary Shares, par value NIS 0.0000769 per share20790.00.0
2026-08-07
2026-08-07
Ellis SeanA · Grant / award
Acquired
Ordinary Shares, par value NIS 0.0000769 per share20034.00.0
2026-08-07
2026-08-07
Ellis SeanA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
40000.00.0
2026-08-07
2026-08-07
Yaacov-Garbeli DanaA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
140000.00.0
2026-08-07
2026-08-07
Galitzer HillelA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
200000.00.0
2026-08-07
2026-08-07
Burshtein GregoryA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
180000.00.0
2026-08-07
2026-08-07
Toledano Miranda JayneA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
500000.00.0
2026-08-07
2026-08-07
Toledano Miranda JayneA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
200000.00.0
2026-08-07
2026-08-07
Germano Geno JA · Grant / award
Acquired
Ordinary Shares, par value NIS 0.0000769 per share25014.00.0
2026-08-07
2026-08-07
Germano Geno JA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
50000.00.0
2026-08-07
2026-08-07
Germano Geno JA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
43014.00.0
2026-07-14
2026-07-16
Toledano Miranda JayneA · Grant / award
Acquired
Ordinary Shares, par value NIS 0.0000769 per share347567.00.0
2026-07-14
2026-07-16
Toledano Miranda JayneA · Grant / award
Acquired
Ordinary Shares, par value NIS 0.0000769 per share72993.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001638097Entera Bio Ltd.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$181.0K$194.4K
    2023-12-31$0$0
    2022-12-31$134.0K$154.3K
    2021-12-31$571.0K$709.9K
    2020-12-31$365.0K$475.2K

    Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

    Explore the CPI history ↗